Why UHC Denies Biologic Therapy (Autoimmune)
Step therapy not completed (conventional DMARDs first)
Prior biologic trial not documented
Biosimilar required before brand-name biologic
Know UnitedHealthcare's Criteria
UHC uses InterQual criteria and their own Clinical UM Guidelines (CG series). Medical directors are typically accessible for P2P within 5 business days.
Key policies to know:
- Requires eviCore for MSK and advanced imaging prior auth
- Clinical UM Guidelines (CG series) are publicly available online
- Prior auth through Optum/UHG portal
- Known for strict step therapy requirements on biologics
UHC's Specific Approach to Biologic Therapy (Autoimmune)
Applicable Policy
UHC Pharmacy Clinical UM Guidelines (varies by drug -- e.g., Humira, Enbrel, Remicade)
How UHC Typically Denies This
UHC has strict step therapy: methotrexate + one conventional DMARD must fail before biologics for RA. For IBD, conventional therapy failure is required. They also mandate biosimilar-first policies for many biologics.
Your Strategy for This Payer
Know the specific step therapy requirements for your patient's diagnosis. Document failure of each step therapy agent with specific reasons (inadequate response, adverse effects, contraindication). If biosimilar is required, have a clinical reason for brand preference.
Key Phrase to Use on the Call
"The patient has failed [methotrexate at X dose for Y months] and [second DMARD] with documented [inadequate response/adverse effects], meeting UHC's step therapy requirements for biologic initiation."
Building Your Medical Necessity Argument
Document failure, intolerance, or contraindication to step therapy agents
Note disease activity scores (DAS28, CDAI, PASI)
If biosimilar switch requested, document clinical reason for brand
Reference comorbidities that limit alternative treatments
P2P Call Tips for UHC
Reference UHC's own Clinical UM Guideline number (e.g., CG-SURG-71)
UHC medical directors respond well to InterQual criteria language
Be specific about which InterQual subset applies
Have the CG policy number ready -- shows you've done your homework
Guidelines to Reference
- ACR Guidelines for Rheumatoid Arthritis Treatment
- AGA Guidelines for Biologic Therapy in IBD
- AAD Guidelines for Biologic Therapy in Psoriasis
Relevant CPT Codes
Specialty: Rheumatology / Gastroenterology / Dermatology
Want the full strategy?
The P2P Playbook covers payer-specific approaches for Biologic Therapy (Autoimmune) denied by UHC -- plus 15 denial objections with word-for-word responses, what reviewers are actually thinking, and the 60-second prep framework. Written by a medical director who reviewed cases for major payers.
Get The P2P Playbook -- $39Get a personalized P2P script in 60 seconds
Enter your specific case details and our AI generates a structured prep script tailored to UHC's criteria.